Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

C1S anticorps

C1S Reactivité: Humain WB, FACS, IHC (p), IP, IHC (fro), IA, InhA Hôte: Souris Monoclonal M81 unconjugated
N° du produit ABIN2191986
  • Antigène Voir toutes C1S Anticorps
    C1S (Complement Component 1, S Subcomponent (C1S))
    Reactivité
    • 62
    • 17
    • 17
    • 2
    • 1
    Humain
    Hôte
    • 46
    • 13
    • 3
    Souris
    Clonalité
    • 50
    • 12
    Monoclonal
    Conjugué
    • 33
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp C1S est non-conjugé
    Application
    • 41
    • 16
    • 15
    • 13
    • 13
    • 11
    • 9
    • 7
    • 7
    • 6
    • 6
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunoprecipitation (IP), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunoassay (IA), Inhibition Assay (InhA)
    Stérilité
    0.2 μm filtered
    Clone
    M81
    Top Product
    Discover our top product C1S Anticorps primaire
  • Indications d'application
    For immunohistology, flow cytometry and Western blotting dilutions to be used depend on detection system applied. It is recommended that users test the reagent and determine their own optimal dilutions. The typical starting working dilution is 1:10. For inhibition of C4 activation by C1s dilutions have to be made according to the amounts C1s to be inactivated.
    Restrictions
    For Research Use only
  • Buffer
    PBS containing 0.1 % bovine serum albumin.
    Stock
    4 °C
    Stockage commentaire
    Product should be stored at 4 °C. Under recommended storage conditions, product is stable for one year.
    Date de péremption
    12 months
  • Matsumoto, Nagaki, Kitamura, Kuramitsu, Nagasawa, Seya: "Probing the C4-binding site on C1s with monoclonal antibodies. Evidence for a C4/C4b-binding site on the gamma-domain." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 142, Issue 8, pp. 2743-50, (1989) (PubMed).

  • Antigène
    C1S (Complement Component 1, S Subcomponent (C1S))
    Autre désignation
    c1s (C1S Produits)
    Synonymes
    anticorps AA959438, anticorps AI255193, anticorps AI327365, anticorps C1sa, anticorps r-gsp, anticorps C1S, anticorps complement C1s, anticorps complement component 1, s subcomponent 1, anticorps complement component 1, s subcomponent, anticorps complement component 1, s subcomponent L homeolog, anticorps complement C1s subcomponent, anticorps C1S, anticorps C1s1, anticorps C1s, anticorps c1s, anticorps c1s.L, anticorps LOC100558615
    Sujet
    Monoclonal antibody M81 reacts with an epitope on human C protein activated C1s, a subcomponent of the first component of C (C1). Activated C1s is a glycosylated single-polypeptide zymogen, MW 85 kD. Activation of the proenzyme C1s occurs through cleavage by the active form of C1r. The activated protease, activated C1s, consists of a disulfide-linked H chain and a L chain. Activated C1s is a serine protease and its catalytic site is located in the L chain. Activation of the classical C pathway is triggered by activated C1s which cleaves C4 and C2 to form the C3 convertase, C4bC2a. The epitope recognised by the antibody M81 is domain IV and/or V of the gamma-domain of activated C1s. Monoclonal antibody M81 blocks C4 activation and C4 binding to activated C1s. The antibody reacts around the binding site of C1s and reacts with both active and inactive C1s.
    Pathways
    Système du Complément
Vous êtes ici:
Support technique